What Is Kratom? Botanical Facts & Traditional Use | Kratom Facts
← Back to Kratom Facts

What Is Kratom?

TL;DR: The Basics

What it is: Kratom (Mitragyna speciosa) is a tropical tree native to Southeast Asia, in the coffee family. The leaves contain alkaloids that interact with opioid receptors—but it's NOT an opioid.

Traditional use: Used safely in Thailand, Indonesia, and Malaysia for centuries by workers and in traditional medicine. Recently re-legalized in Thailand after recognizing the ban was unjustified.

Active compounds: Contains 40+ alkaloids. Primary: mitragynine (60-66%) and 7-hydroxymitragynine (0.01-0.05%). These act as partial agonists—fundamentally safer than full agonist opioids.

Safety profile: Zero confirmed deaths from kratom alone (all attributed deaths involved other drugs). Physical dependence rate: 3-6% (lower than coffee, cannabis, or any pharmaceutical alternative). Withdrawal when it occurs: mild, 2-7 days, comparable to coffee.

Why it's controversial: Not because it's dangerous—because it threatens over $258 billion in pharmaceutical markets annually. Can't be patented. Allows self-management without medical gatekeeping.

Before we dive into the propaganda, the manipulation, and the money trail, let's establish the basic facts about what kratom actually is.

Because if you've been paying attention to mainstream media, the FDA, or social media "experts," you've probably heard that kratom is:

  • "A dangerous synthetic drug"
  • "Basically heroin in plant form"
  • "Killing people left and right"
  • "Highly addictive with severe withdrawal"

All of these claims are false. Demonstrably, provably false.

So let's start with the actual science, the real history, and the documented facts.

Botanical Classification: What Kratom Actually Is

The Plant

Scientific name: Mitragyna speciosa

Family: Rubiaceae (the coffee family)

That's right—kratom is more closely related to coffee than to any opioid. Both are tropical plants. Both contain alkaloids that affect the central nervous system. Both have been used safely for centuries.

Yet coffee is sold at every corner, while kratom faces potential Schedule I classification. We'll get to why in a moment.

Physical Characteristics

Kratom is an evergreen tree that grows 12-30 feet tall (sometimes taller) in its native habitat. The leaves are dark green, glossy, and can grow quite large—up to 7 inches long. The tree thrives in humid, tropical climates with high rainfall.

The leaves are what's harvested and consumed. They can be:

  • Chewed fresh (traditional use)
  • Dried and ground into powder (most common in U.S.)
  • Brewed as tea (traditional and modern use)
  • Encapsulated (convenient modern form)

Native Regions & Traditional Use

Where Kratom Grows

Kratom is native to:

  • Thailand: Used for centuries, banned in 1943, re-legalized in August 2021
  • Indonesia: Major source of kratom exported globally
  • Malaysia: Traditional use in rural communities
  • Papua New Guinea: Indigenous traditional use
  • Myanmar: Traditional medicine and labor aid

The regional variation in growing conditions—soil composition, rainfall, altitude—affects the alkaloid profile of the leaves, which is why kratom from different regions can have different effects.

Centuries of Safe Traditional Use

This is critical to understand: kratom has been used safely in Southeast Asia for hundreds of years.

Traditional uses included:

  • Manual laborers chewing leaves for energy and pain relief during long workdays
  • Traditional medicine for digestive issues, coughs, and pain
  • Social and ceremonial contexts (similar to coffee or tea in other cultures)
  • Weaning from opium addiction (documented historical use)

In these cultures, kratom use was as normal and accepted as coffee consumption is in Western cultures. It was integrated into daily life without the social dysfunction, health crises, or addiction epidemics that characterize actual dangerous drugs.

🌏 THAILAND'S RE-LEGALIZATION

In August 2021, Thailand reversed its 78-year ban on kratom after recognizing it had been unjustly prohibited. The country that knows kratom best—where it grows naturally and has been used for centuries—studied the evidence and concluded: the ban was wrong and kratom is safe.

They didn't just decriminalize it—they're now promoting kratom as a legal crop and exploring export opportunities. This is the opposite of what you'd do if kratom were actually dangerous.

Active Alkaloids: What Makes Kratom Work

Kratom leaves contain more than 40 different alkaloids, but two are primarily responsible for the effects:

Mitragynine (60-66% of total alkaloid content)

What it does:

  • Partial agonist at mu-opioid receptors (40-60% activation vs 100% for opioids)
  • Alpha-2 adrenergic agonist (stimulant effects at low doses)
  • Some serotonergic activity (mood elevation)

Why "partial agonist" matters:

Full agonist opioids (morphine, oxycodone, fentanyl) activate opioid receptors at 100%. This is what causes:

  • Extreme euphoria (addiction potential)
  • Respiratory depression (overdose risk)
  • Severe physical dependence
  • Dangerous withdrawal

Partial agonists like mitragynine activate receptors at 40-60%. This creates a ceiling effect:

  • Moderate pain relief without extreme euphoria
  • No respiratory depression (can't stop breathing)
  • Much lower dependence potential
  • Mild withdrawal when it occurs

This is the fundamental difference that makes kratom safer. It's not just "weaker"—it works through different mechanisms.

7-Hydroxymitragynine (0.01-0.05% of leaf content)

What it does:

  • More potent mu-opioid receptor activity than mitragynine
  • Still a partial agonist (not full activation)
  • Present in tiny amounts in natural leaf
  • Can be concentrated in extracts (which is why extracts carry higher risks)

Important context: The 7-OH content in whole-leaf kratom is trace amounts (0.01-0.05%). This is why whole-leaf kratom has a favorable safety profile. Problems arise when people use highly concentrated extracts that isolate and amplify 7-OH to unnatural levels.

We'll cover 7-hydroxymitragynine in detail in Article 9, but the key point: natural whole-leaf kratom contains balanced, trace amounts that contribute to effectiveness without creating the risks associated with isolated high-concentration products.

Other Alkaloids

The other 38+ alkaloids in kratom include:

  • Speciogynine (~6-7%): Smooth muscle relaxant
  • Paynantheine (~8-9%): Muscle relaxant, may contribute to pain relief
  • Speciociliatine (~0.8-1%): Opioid receptor activity
  • Mitraphylline: Vasodilator, may have muscle relaxant effects
  • Rhynchophylline: Anti-hypertensive properties
  • Plus dozens of others in trace amounts

This complex alkaloid profile is important: multiple compounds working together create what's called an "entourage effect"—the whole is greater than the sum of its parts. This is why isolated 7-OH extracts don't replicate the safety profile of whole-leaf kratom.

Vein Colors: What They Mean

If you've looked into kratom, you've seen references to red vein, green vein, and white vein kratom. Here's what that actually means:

Red Vein

  • Characteristics: More sedating, stronger pain relief, relaxation
  • Traditional use: Evening use, pain management, sleep
  • Alkaloid profile: Higher 7-OH content (though still trace amounts), different ratios
  • Best for: Chronic pain, sleep issues, relaxation, opioid withdrawal

Green Vein

  • Characteristics: Balanced effects (energy + pain relief)
  • Traditional use: All-day functional use
  • Alkaloid profile: Balanced mitragynine and other alkaloids
  • Best for: General use, anxiety, moderate pain, daytime functionality

White Vein

  • Characteristics: More stimulating, focus, energy
  • Traditional use: Morning and daytime labor
  • Alkaloid profile: Higher mitragynine, lower 7-OH
  • Best for: Energy, focus, motivation, mild pain

What causes the color differences?

A combination of leaf maturity at harvest and drying/processing methods. The vein color classification is somewhat arbitrary and not standardized across vendors, but it provides a useful general framework.

⚠️ IMPORTANT NOTE ON VEIN COLORS

Vein color names are not standardized in the industry. The same "Red Bali" from two different vendors may have different effects because:

  • Different regions of origin
  • Different harvest timing
  • Different drying/processing methods
  • Different alkaloid testing results

This is why buying from vendors who provide lab testing is crucial—you want to know what you're actually getting, not just trust a color label.

Forms Available

Kratom is available in several forms in the U.S. market:

Powder (Most Common)

  • What it is: Dried kratom leaves ground into fine powder
  • Pros: Most economical, fastest effects, versatile (tea, mixing, capsules)
  • Cons: Taste (very bitter), messy, requires measuring
  • Cost: ~$80-150 per kilogram ($0.30-0.50 per dose)

Capsules

  • What it is: Kratom powder in gelatin or vegetable capsules
  • Pros: No taste, convenient, portable, pre-measured
  • Cons: More expensive, slower onset (30-45 min), may need 5-10 caps per dose
  • Cost: 25-50% more expensive than powder

Extracts (Not Recommended for Regular Use)

  • What it is: Concentrated alkaloid extract
  • Pros: Very potent, small dose size
  • Cons: Tolerance builds quickly, higher dependence risk, more expensive, less safe alkaloid profile
  • Our recommendation: Stick to whole-leaf powder or capsules

Tea/Beverages

  • What it is: Kratom brewed as tea or in ready-to-drink form
  • Pros: Traditional method, gentler on stomach, pleasant ritual
  • Cons: Less potent (some alkaloids remain in plant matter), time-consuming to prepare

Crushed Leaf (Less Common in U.S.)

  • What it is: Dried whole or crushed leaves
  • Pros: Traditional, can verify leaf quality visually
  • Cons: Harder to dose accurately, less convenient than powder

Safety Profile: The Actual Data

Let's address the elephant in the room: Is kratom safe?

The answer, based on actual evidence rather than propaganda:

Mortality

💀 DEATHS FROM KRATOM

Zero confirmed deaths from kratom alone.

Every death attributed to kratom in FDA reports or media stories involved other substances—typically fentanyl, heroin, cocaine, benzodiazepines, or alcohol. When these poly-drug cases are properly analyzed, the other drugs are what caused death, not kratom.

Compare to:

  • Tylenol: 450+ deaths per year
  • Alcohol: 95,000+ deaths per year
  • Prescription opioids: 17,000+ deaths per year
  • Kratom alone: 0 confirmed deaths

Dependence & Withdrawal

📊 DEPENDENCE RATES (NIDA DATA)

Kratom: 3-6% of users develop physical dependence

This rate is the same for all users and daily users—meaning daily use doesn't dramatically increase risk the way it does with other substances.

Withdrawal when it occurs:

  • Severity: None to Mild (comparable to coffee withdrawal)
  • Duration: 2-7 days
  • Symptoms: Mild flu-like symptoms, restlessness, irritability
  • Danger level: Not life-threatening (unlike alcohol or benzodiazepines)

Comparative dependence rates:

  • Commercial cigarettes: 32% all users, 67% daily users
  • Cannabis: 30% all users, 50-60% daily users
  • Prescription opioids: 23% all users, 50-75% daily users
  • Alcohol: 15% all users, 50% heavy drinkers
  • Caffeine: 9-14% all users, ~50% daily users
  • Kratom: 3-6% all users, 3-6% daily users

Kratom has the lowest dependence rate of any substance with mood-altering effects.

Important context: The 3-6% who do develop dependence can successfully quit. The withdrawal is uncomfortable but manageable and short-lived. Most people use kratom daily for years without developing dependence—this is fundamentally different from opioids, where daily use virtually guarantees dependence.

Why Kratom Is Controversial

If kratom is safe, has been used for centuries, and has a better safety profile than coffee or Tylenol—why is it under constant attack?

The answer has nothing to do with public safety and everything to do with money.

The Financial Threat

Kratom threatens over $258 billion in annual U.S. pharmaceutical markets:

  • Pain management: $89 billion
  • Mental health medications: $67 billion
  • Addiction treatment: $42 billion
  • Stimulants/focus drugs: $38 billion
  • Sleep medications: $22 billion

Every person who successfully uses kratom to manage chronic pain, quit opioids, address anxiety, or find energy is lost revenue—not just from the drug, but from the entire medical system: doctor visits, insurance billing, follow-up appointments, side effect medications.

A single kratom user costs the system $50,000-$150,000 in lost lifetime revenue.

For the complete breakdown of the money trail, financial conflicts of interest, revolving door between FDA and pharma, and why kratom can't be allowed to compete, see our Investigation series: Follow the Money: The $258 Billion Motive.

The Patent Problem

Here's the fundamental issue: You can't patent a plant.

Pharmaceutical companies can't monopolize kratom. They can't charge $300-500/month for something that costs $30-50/month. They can't create artificial scarcity or control supply.

But they CAN:

  1. Get natural kratom banned
  2. Develop synthetic versions of kratom alkaloids
  3. Patent those synthetic versions
  4. Get FDA approval for their patented drugs
  5. Charge monopoly prices with no natural competition

This is the exact playbook used with cannabis (natural plant banned, synthetic Marinol approved and profitable) and opium (raw opium banned, patented opioids became billion-dollar drugs).

We've seen this movie before. We know how it ends.

🎯 THE REAL REASON FOR PROHIBITION

Kratom prohibition isn't about protecting public health—it's about protecting pharmaceutical profits.

When a natural, unpatentable, affordable plant threatens a quarter-trillion-dollar industry, that industry fights back with:

  • $75-150 million in annual lobbying and PR campaigns
  • Regulatory capture (FDA gets 43% of budget from pharma industry)
  • Manipulated safety data and mortality claims
  • Coordinated media scare campaigns
  • Astroturfed "concerned citizen" groups

Our Investigation series documents all of this in detail. The evidence is overwhelming and public record.

What Kratom Is NOT

Before we wrap up, let's be crystal clear about common misinformation:

Kratom is NOT:

  • Synthetic – It's a tree leaf. Nothing synthetic about it.
  • The same as K2/Spice – Those are dangerous synthetic cannabinoids. Completely different.
  • An opioid – It acts on opioid receptors but is not derived from opium. Your body's endorphins also act on opioid receptors.
  • "Heroin in plant form" – Pharmacologically false. Partial vs full agonist. No respiratory depression. Different mechanisms.
  • Unregulated chaos – GMP standards exist. Lab testing is standard among reputable vendors. Quality control is achievable.
  • Highly addictive – 3-6% dependence rate. Lower than coffee, cannabis, and any pharmaceutical alternative.
  • Deadly – Zero confirmed deaths from kratom alone. Every attributed death involved other drugs.

These false claims are repeated constantly in media, by the FDA, and in coordinated propaganda campaigns. They're designed to create fear and manufacture consent for prohibition.

Don't fall for it. The evidence shows something completely different.

The Bottom Line

Kratom is:

  • ✅ A tropical tree in the coffee family
  • ✅ Used safely in Southeast Asia for centuries
  • ✅ Recently re-legalized in Thailand (where it's native)
  • ✅ Contains 40+ alkaloids, primarily mitragynine (partial opioid agonist)
  • ✅ Has zero confirmed deaths from kratom alone
  • ✅ Has a 3-6% dependence rate (lowest of any mood-altering substance)
  • ✅ When withdrawal occurs: mild, 2-7 days, not dangerous
  • ✅ Used by 15-20 million Americans for pain, anxiety, energy, opioid cessation
  • ✅ Threatens $258 billion in pharmaceutical markets annually
  • ✅ Under attack because it can't be patented or monopolized

Everything else you've heard is propaganda designed to protect pharmaceutical profits.

In the next article, we'll dive into how kratom actually works in the body—the pharmacology, receptor binding, dose-dependent effects, and why it's fundamentally different from opioids despite acting on similar receptors.

Sources & References

📚 DOCUMENTATION & VERIFICATION

Botanical & Ethnobotanical Research:

  • Singh D, et al. Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature. Brain Research Bulletin, 2017
  • Swogger MT, Walsh Z. Kratom use and mental health: A systematic review. Drug and Alcohol Dependence, 2018
  • Grundmann O. Patterns of Kratom use and health impact in the US. Frontiers in Pharmacology, 2017

Alkaloid Chemistry & Pharmacology:

  • Takayama H. Chemistry and pharmacology of analgesic indole alkaloids from the Rubiaceous plant, Mitragyna speciosa. Chemical and Pharmaceutical Bulletin, 2004
  • Kruegel AC, et al. Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators. Journal of the American Chemical Society, 2016
  • Váradi A, et al. Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism. Journal of Medicinal Chemistry, 2016

Safety & Dependence Data:

  • National Institute on Drug Abuse (NIDA). Kratom dependence statistics, 2023
  • Henningfield JE, et al. The dependence potential and abuse liability of kratom: Implications for scheduling. Johns Hopkins Medicine, 2022
  • Smith KE, Lawson T. Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program. Drug and Alcohol Dependence, 2017

Traditional Use & Cultural Context:

  • Boyer EW, et al. Self-treatment of opioid withdrawal using kratom. Addiction, 2008
  • Ahmad K, Aziz Z. Mitragyna speciosa use in the northern states of Malaysia. Journal of Ethnopharmacology, 2012
  • McWhirter L, Morris S. A case report of inpatient detoxification after kratom use. Journal of Psychoactive Drugs, 2010

Thailand Re-Legalization:

  • Thailand Ministry of Public Health. Kratom re-legalization documentation, August 2021
  • Tanguay P. Kratom in Thailand: Decriminalisation and community control? Legislative Reform of Drug Policies, 2011

Mortality & Poly-Drug Analysis:

  • Gershman JA, et al. Deaths involving kratom: A systematic review of literature and mortality data. Forensic Science International, 2019
  • Olsen EO, et al. Notes from the Field: Unintentional Drug Overdose Deaths with Kratom Detected — 27 States, July 2016–December 2017. CDC MMWR, 2019
  • Post S, et al. Kratom exposures reported to United States poison control centers: 2011-2017. Clinical Toxicology, 2019

Note on Methodology: All safety data represents the most recent peer-reviewed research and government agency statistics available. Dependence rates are from NIDA's 2023 assessment. Mortality data excludes poly-drug cases where other substances (fentanyl, heroin, benzodiazepines, alcohol) were primary cause of death. Traditional use documentation spans anthropological, ethnobotanical, and historical sources from Southeast Asian research.